14 April - 15 April 2021

37th Process Development Symposium 2021

Organised by:

SCI's Fine Chemicals Group

Online Webinar

Register your interest
Synopsis
Process Development is the application of chemistry to the scale up of new synthetic processes from the laboratory, through pilot plant to full-scale commercial manufacture and into life cycle management. It is an extremely broad discipline, crossing the boundaries between synthetic organic chemistry, process technology and chemical engineering. The area of Process Development continues to be a challenging and important area for the research into and application of modern synthetic organic chemistry, as well as enabling technologies.
Attendees
The symposium aims to bring together a wide range of speakers from across the Pharmaceutical, Agrochemical and Fine Chemical industries, as well as from an academic background. This meeting brings together experts from across the entire spectrum of the discipline to present state-of-the-art process development.
Programme
-

Process chemistry award winner 2019: Design, development and applications of catalytic synthesis methods based on phosphorus and silicon
Prof Ross Denton, University of Nottingham, UK

-
Experimental design and its place in process development
Dr Laura Forfar, Catalysis Consulting Ltd, UK
-
Process development in the synthesis of CF corrector VX-661
Dr Cristian Harrison, Vertex pharmaceuticals, USA
-
Automation and autonomy to enable process chemistry
Prof Jason Hein, University of British Columbia, Canada
-
Application of transition-metal catalysis, biocatalysis and flow chemistry as state-of-the-art technologies in the synthesis of LCZ696
Dr Florian Kleinbeck, Novartis, Switzerland
-
Site-specific and enantioselective sp3 C-H functionalization
Prof Guosheng Liu, SIOC, China 
-
Probing reagent / catalyst (dis)function
Prof Guy Lloyd Jones, University of Edinburgh, UK
-
New perspectives: approaches for the application of metal scavengers to impurity control in pharma
Dr Sunil Rana, Biotage GB Ltd, UK
-
An enantioselective total synthesis of (+)-duocarmycin SA
Dr Michael Schmidt, Bristol Myers Squibb, USA
-
The application of C-H functionalisation in the development of a concise and convergent route to nemiralisib
Dr Katherine Wheelhouse, GlaxoSmithKline, UK
-
Particle design and modelling technologies for API manufacturing
Dr Claire Wombwell, Johnson Matthey, UK
  
Other confirmed speakers
  • Dr Julia Baumeister, Syngenta, Switzerland
  • Dr Rachel Sullivan, AstraZeneca, UK
  • Dr Sue Zultanski, Merck, USA

Booking Process/Deadlines

Booking terms and conditions


CPD Info

SCI Members attending this meeting are able to claim CPD points.


Sponsors

Organising Committee
  • Louis Diorazio, SCI/AstraZeneca

  • Max Espensen, Pharmaron

  • Stella James, SCI/Bionow

  • Dave Lathbury, SCI/Astute Chemical Development Ltd

  • David Pascoe, SCI/GlaxoSmithKline

  • Hazmi Tajuddin, SCI/Syngenta

  • Robert Walton, SCI/Pfizer

  • Hilmar Weinman, Janssen Pharmaceutical Companies of Johnson & Johnson

  • Andy Wells, Charnwood Technical Consulting Ltd 


Exhibition and Sponsorship

For further information and prices please email jacqui.maguire@soci.org


Conference team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org